When the results of the multivariate analysis were examined, it was seen that the use of SGLT2 inhibitor (odds ratio (OR): 0.41, 95% confidence interval (CI): 0.142–0.966, p = 0.004) and the high eGFR value (odds ratio (OR): 0.722, 95% confidence interval (CI): 0.591–0.881, p = 0.001) were found to be the only protective factors for CIN. This evidence concerns the gene SLC5A2 and cervical squamous intraepithelial neoplasia.